Interferon regulatory factor-2 directs transcription from the gp91(phox) promoter

被引:61
作者
Luo, W
Skalnik, DG
机构
[1] JAMES WHITCOMB RILEY HOSP CHILDREN,HERMAN B WELLS CTR PEDIAT RES,SECT PEDIAT HEMATOL ONCOL,INDIANAPOLIS,IN 46202
[2] INDIANA UNIV,SCH MED,DEPT PEDIAT,INDIANAPOLIS,IN 46202
[3] INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOL BIOL,INDIANAPOLIS,IN 46202
关键词
D O I
10.1074/jbc.271.38.23445
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Repressor elements in the gp91(phox) promoter are necessary to restrict tissue-specific transcription to mature phagocytes. Deletion of these elements leads to significant promoter activity in cell lines such as HEL and K562 that do not normally express gp91(phox). The -100 to +12 base pair gp91(phox) promoter region is sufficient to direct maximal de repressed transcription in these cells. However, promoter activity is dramatically decreased following a 16-base pair truncation that deletes an interferon-stimulated response element. This element interacts with IRF-1 and IRF-2, members of the interferon regulatory factor family of transcription factors. In addition, this promoter region is bound by a factor with properties similar to BID, a DNA-binding protein that also interacts with three upstream sites within the gp91(phox) promoter. Transient transfection studies using mutated promoters indicate that both the IRF and BID binding sites are required for maximal gp91(phox) promoter activity. Overexpression of IRF-1 or IRF-2 in K562 cells leads to transactivation of gp91(phox) promoter constructs, which is dependent on the presence of an intact IRF binding site. IRF-2 predominates in macrophages that express the gp91(phox) gene as well as in HEL and K562 cells. We conclude that IRF-2 and BID activate gp91(phox) promoter activity in the absence of transcriptional repression.
引用
收藏
页码:23445 / 23451
页数:7
相关论文
共 50 条
[11]   ISGF3, THE TRANSCRIPTIONAL ACTIVATOR INDUCED BY INTERFERON-ALPHA, CONSISTS OF MULTIPLE INTERACTING POLYPEPTIDE-CHAINS [J].
FU, XY ;
KESSLER, DS ;
VEALS, SA ;
LEVY, DE ;
DARNELL, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) :8555-8559
[12]  
GEY GO, 1952, CANCER RES, V12, P264
[13]  
GOSH D, 1993, NUCLEIC ACIDS RES, V21, P3117
[14]   ANTI-ONCOGENIC AND ONCOGENIC POTENTIALS OF INTERFERON REGULATORY FACTOR-I AND FACTOR-II [J].
HARADA, H ;
KITAGAWA, M ;
TANAKA, N ;
YAMAMOTO, H ;
HARADA, K ;
ISHIHARA, M ;
TANIGUCHI, T .
SCIENCE, 1993, 259 (5097) :971-974
[15]   STRUCTURALLY SIMILAR BUT FUNCTIONALLY DISTINCT FACTORS, IRF-1 AND IRF-2, BIND TO THE SAME REGULATORY ELEMENTS OF IFN AND IFN-INDUCIBLE GENES [J].
HARADA, H ;
FUJITA, T ;
MIYAMOTO, M ;
KIMURA, Y ;
MARUYAMA, M ;
FURIA, A ;
MIYATA, T ;
TANIGUCHI, T .
CELL, 1989, 58 (04) :729-739
[16]   REQUIREMENT FOR TRANSCRIPTION FACTOR IRF-1 IN NO SYNTHASE INDUCTION IN MACROPHAGES [J].
KAMIJO, R ;
HARADA, H ;
MATSUYAMA, T ;
BOSLAND, M ;
GERECITANO, J ;
SHAPIRO, D ;
LE, J ;
KOH, SI ;
KIMURA, T ;
GREEN, SJ ;
MAK, TW ;
TANIGUCHI, T ;
VILCEK, J .
SCIENCE, 1994, 263 (5153) :1612-1615
[17]   THE MACROPHAGE AND B-CELL SPECIFIC TRANSCRIPTION FACTOR PU.1 IS RELATED TO THE ETS ONCOGENE [J].
KLEMSZ, MJ ;
MCKERCHER, SR ;
CELADA, A ;
VANBEVEREN, C ;
MAKI, RA .
CELL, 1990, 61 (01) :113-124
[18]   HUMAN PERIPHERAL EOSINOPHILS HAVE A SPECIFIC MECHANISM TO EXPRESS GP91-PHOX, THE LARGE SUBUNIT OF CYTOCHROME B(558) [J].
KURIBAYASHI, F ;
KUMATORI, A ;
SUZUKI, S ;
NAKAMURA, M ;
MATSUMOTO, T ;
TSUJI, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (01) :146-152
[19]   POLARITY-SPECIFIC ACTIVITIES OF RETINOIC ACID RECEPTORS DETERMINED BY A CO-REPRESSOR [J].
KUROKAWA, R ;
SODERSTROM, M ;
HORLEIN, A ;
HALACHMI, S ;
BROWN, M ;
ROSENFELD, MG ;
GLASS, CK .
NATURE, 1995, 377 (6548) :451-454
[20]  
LEE TC, 1994, ONCOGENE, V9, P1047